Cholinergic Antagonists
3
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Topical Placebo Spray
Research Leaders
11 sponsors active, led by Ludwig-Maximilians - University of Munich
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
DBI - Tool for Medication Reviews in Older People
Research Network
Common Treatments
- Topical Placebo Spray1
- Medication Review1
- Oxybutynin1
- Control Intervention1
- Partner Intervention1
Active Sponsors
- Ludwig-Maximilians - University of Munich1
- University Hospital Regensburg1
- Samantha Rodrigues Camargo Neves de Moura1
- University of Groningen1
- Bielefeld University1
Top Investigators
Science Valley Research Institute
Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany
University of Groningen
Related Conditions
- Autonomic Agents1
- Sweat Gland Diseases1
- Hypnotics And Sedatives1
- Parasympatholytics1
- Antidepressive Agents1